COO  Cooper Companies Inc. (The)

Exchange

NYSE

Sector

Health Care

Industry

Ophthalmic Goods

Market Cap.

8.84B

Vuru Grade

48.79/100

Current Price

$182.47
+1.53 (+0.85%)

Growth Price

$74.71
Overvalued by 59.05%

Company Metrics

  • P/E 43.17
  • P/S 4.74
  • P/B 3.2
  • EPS 4.23
  • Cash ROIC 7.18%
  • Cash Ratio 0.03
  • Dividend 0.06 / 0.03%
  • Avg. Vol. 400,757.00
  • Shares 48.45M
  • Market Cap. 8.84B

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

The Cooper Companies Inc Stock Technicals Hit Strength
CML News - Jul 20, 2016
This is a technical analysis stock rating for The Cooper Companies Inc (NYSE:COO) . The company has a four bull technical rating which indicates some strength.
The Cooper Companies Inc versus DENTSPLY SIRONA Inc Head to Head Compare
CML News - Jul 29, 2016
The Cooper Companies Inc has a higher fundamental rating than DENTSPLY SIRONA Inc which has an impact on the head-to-head comparison.
Equity Review: Focusing on Shares of The Cooper Companies Inc. (NYSE:COO)
Press Telegraph - 3 hours ago
When speculating how a given stock will perform in the future, it is important to look at how it has performed in the past. Today we will examine how The Cooper Companies Inc. (NYSE:COO)'s stock has performed at various points in its past. Currently ...
The Cooper Companies Acquires Assets of Recombine
GlobeNewswire (press release) - May 25, 2016
PLEASANTON, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier ...
Cooper Acquires Assets of Recombine for $85 Million (NYSE:COO) - Sonoran Weekly Review
Ex-Dividend Reminder: Procter & Gamble, Cooper Companies and Hospitality ...
Forbes - Jul 18, 2016
Looking at the universe of stocks we cover at Dividend Channel, on 7/20/16, Procter & Gamble Co. (NYSE: PG), Cooper Companies, Inc. (NYSE: COO), and Hospitality Properties Trust (NASD: HPT) will all trade ex-dividend for their respective upcoming ...
Cooper Companies Inc (COO) VP Sells $334620.00 in Stock
The Cerbat Gem - Jun 29, 2016
Cooper Companies logo Cooper Companies Inc (NYSE:COO) VP Randal Golden sold 2,000 shares of the firm's stock in a transaction on Tuesday, June 28th.
The Cooper Companies Inc (COO) President & CEO Robert S Weiss Sold $24.8 ... - GuruFocus.com
Cooper Companies Inc (COO) Director Sells $1700000.00 in Stock - Community Financial News
Cooper Companies Inc Stock Is An 52-Week High Flier
Consumer Eagle - Jul 29, 2016
The stock of Cooper Companies Inc (NYSE:COO) hit a new 52-week high and has $265.18 target or 45.00% above today's $182.88 share price.
JP Morgan Initiates Coverage on Cooper Companies Inc to Buy
Trade Calls - Jul 20, 2016
JP Morgan Initiates Coverage on Cooper Companies Inc(NYSE:COO). The shares have been rated Buy. The rating by JP Morgan was issued on Jul 13, 2016.
Handelsbanken Fonder Ab Lowers stake in Cooper Companies Inc (COO) - TheFounders Daily
Geode Capital Management LLC Purchases 21134 Shares of The Cooper Cos. (COO) - The Cerbat Gem
Momentum Rating: Cooper Companies Inc (NYSE:COO)
Enterprise Leader - Jul 29, 2016
Cooper Companies Inc (NYSE:COO) has reserved a top momentum style rating from Zacks Research. The momentum rating acts as an important barometer to show as to when a stock will attain a favourable position, which will provide a window of ...
Cooper Companies Inc (NYSE:COO): Quarterly EPS Estimate Of $2.23
Equities Focus - Jul 29, 2016
EPS projections 7 and 30 days ago were $2.23 and $2.23 respectively. Analysts projected $2.23 and $2.23 respectively as EPS 60 and 90 days ago.